Oral treatment in diabetes.
D000092:Acetohexamide; D000138:Acidosis / Q000150:complications; D000284:Administration, Oral; D000818:Animals; D001645:Biguanides / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology; D002747:Chlorpropamide; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000378:metabolism; D005905:Glyburide; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology; D008099:Liver / Q000187:drug effects; D009765:Obesity / Q000150:complications; D013329:Structure-Activity Relationship; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D014042:Tolazamide; D014044:Tolbutamide
D001645:Biguanides; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D014042:Tolazamide; D000092:Acetohexamide; D005905:Glyburide; D002747:Chlorpropamide